HIV-associated bacteremia: How it has changed in the highly active antiretroviral therapy (HAART) era

Journal of Acquired Immune Deficiency Syndromes

Volumn 23, Issue 2, 2000, Pages 145-151

  Tumbarello, Mario ^a   Tacconelli, Evelina ^a   De Gaetano Donati, Katleen ^a   Citton, Rita ^a   Leone, Fiammetta ^a   Spanu, Teresa ^a   Cauda, Roberto ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Bacteremia; HAART; HIV

Indexed keywords

DIDANOSINE; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ADULT; ARTICLE; BACTEREMIA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; SCORING SYSTEM; TREATMENT OUTCOME;

EID: 0034144261     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200002010-00006     Document Type: Article

References (20)

1. Simberkoff MS, Leaf HL. Bacterial infections in patients with HIV infection. In: Wormser EP, ed. AIDS and other manifestations of HIV infection, 2nd ed. New York: Raven Press, 1992:269-75.
2. Brettle RP. Bacterial infections in HIV: the extent and nature of the problem, Int J STD AIDS 1997;8:5-15.
3. Northfelt DW, Polsky B. Bacteremia in persons with HIV infection. AIDS Clin Rev 1991;5:61-79.
4. Tumbarello M, Tacconelli E, Caponera S, Cauda R, Ortona L. The impact of bacteremia on HIV infection. Nine years experience in a large Italian university hospital. J Infect 1995;31:123-31.
5. Tumbarello M, Tacconelli E, de Gaetano Donati K, et al. Nosocomial bloodstream infections in HIV-infected patient: attributable mortality and excess hospital stay. J Acquir Immun Def Synd 1998; 19:490-6.
6. Hickey MM, Shanson DC. Septicaemia in patients with and without AIDS at Westminster Hospital, London. J Infect 1993;27:243-50.
7. Fichtenbaum CJ, Claiboune Dunagan W, Powderly WG. Bacteremia in hospitalized patients infected with HIV; a case control study of risk factors and outcome. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:51-7.
8. Zurlo JJ, Lane HC. Other bacterial infection. In: De Vita VT, Hellman S, Rosemberg SA, eds. AIDS: etiology, diagnosis, treatment and prevention, 4th ed. Philadelphia - New York: Lippincott-Raven, 1997:259-65.
9. Moore RD, Keruly J, Richamn DD, Creagh-Kirk T, Chaisson RE. The Zidovudine Epidemiology Study Group. Natural history of advanced HIV disease in patients treated with zidovudine. AIDS 1992;6:671-7.
10. Deeks SG, Smith M, Holodniy, Kahn JO. HIV-1 protease inhibitors. A review for clinicians. JAMA 1997;277:145-53.
11. Brodt HR, Kamps BS, Gute P, Knupp B, Staszewski, Helm EB. Changing incidence of AIDS-defining illnesses in the era of anti-retroviral combination therapy. AIDS 1997;11:1731-8.
12. Mouton Y, Alfandari S, Valette M, et al. Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. AIDS 1997;11:F101-5.
13. Jacobson MA, French M. Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy. AIDS 1998;12:S157-63.
14. Paul S, Gilbert HM, Ziecheck W, Jacobs J, Sepkowitz KA. The impact of potent antiretroviral therapy on the characteristics of hospitalized patients with HIV infections. AIDS 1999;13:415-8.
15. Tacconelli E, Tumbarello M, de Gaetano K, Cauda R, Ortona L. Highly active antiretroviral therapy decreases the incidence of bacteremia in HIV-infected individuals. Clin Infect Dis 1998;27: 901-2.
16. Garner JS, Jarvis WR, Emoti TG. CDC definition for nosocomial infections. Am J Infect Control 1988;16:128-140.
17. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991;100:1619-36.
18. Chiasson MA, Berenson L, Li W, et al. Declining mortality in New York City. JAIDS J Acquir Immune Defic Syndr 1999;21:59-64.
19. Tumbarello M, Tacconelli E, de Gaetano K, et al. Bacterial pneumonia in HIV-infected patients. Analysis of risk and prognostic indicators. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18: 39-45.
20. Tumbarello M, Tacconelli E, Cauda R, Ortona L. Role of trimethoprim-sulphametoxazole in preventing HIV-associated bacteremia. AIDS 1997;11:1070-1.